Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1984 Oct;81(20):6388–6392. doi: 10.1073/pnas.81.20.6388

Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state.

B P Bean
PMCID: PMC391929  PMID: 6093100

Abstract

Block of Ca2+ currents by the dihydropyridine drug nitrendipine was studied in single canine ventricular cells by using the whole-cell variant of the patch clamp technique. When cells were held at depolarized membrane potentials at which Ca2+ currents were approximately equal to 70% inactivated, nitrendipine blocked Ca2+ currents very potently, with half-block by subnanomolar concentrations. The concentration dependence of block had the form expected for 1:1 binding, with an apparent dissociation constant (Kd) of 0.36 nM. In contrast, when cells were held at hyperpolarized potentials, nitrendipine blocked Ca2+ currents much less potently (Kd approximately equal to 700 nM). The results can be explained if nitrendipine binds very tightly to the inactivated state of the Ca2+ channel and only weakly to the normal resting state. The Kd estimated for binding to the inactivated state is very similar to the dissociation constants previously found for high-affinity [3H]nitrendipine binding to membrane fragments from heart, smooth muscle, brain, and other tissues; moreover, the concentration-dependent kinetics of binding to the inactivated state are similar to those reported for [3H]nitrendipine binding to membranes. These results make it seem very likely that the high-affinity [3H]nitrendipine binding site is an inactivated state of the Ca2+ channel.

Full text

PDF
6388

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bean B. P., Cohen C. J., Tsien R. W. Lidocaine block of cardiac sodium channels. J Gen Physiol. 1983 May;81(5):613–642. doi: 10.1085/jgp.81.5.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bellemann P., Ferry D., Lübbecke F., Glossman H. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes. Arzneimittelforschung. 1981;31(12):2064–2067. [PubMed] [Google Scholar]
  3. Bolger G. T., Gengo P. J., Luchowski E. M., Siegel H., Triggle D. J., Janis R. A. High affinity binding of a calcium channel antagonist to smooth and cardiac muscle. Biochem Biophys Res Commun. 1982 Feb 26;104(4):1604–1609. doi: 10.1016/0006-291x(82)91436-x. [DOI] [PubMed] [Google Scholar]
  4. Bolger G. T., Gengo P., Klockowski R., Luchowski E., Siegel H., Janis R. A., Triggle A. M., Triggle D. J. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle. J Pharmacol Exp Ther. 1983 May;225(2):291–309. [PubMed] [Google Scholar]
  5. Braunwald E. Mechanism of action of calcium-channel-blocking agents. N Engl J Med. 1982 Dec 23;307(26):1618–1627. doi: 10.1056/NEJM198212233072605. [DOI] [PubMed] [Google Scholar]
  6. Bustamante J. O., Watanabe T., Murphy D. A., McDonald T. F. Isolation of single atrial and ventricular cells from the human heart. Can Med Assoc J. 1982 Apr 1;126(7):791–793. [PMC free article] [PubMed] [Google Scholar]
  7. Byerly L., Hagiwara S. Calcium currents in internally perfused nerve cell bodies of Limnea stagnalis. J Physiol. 1982 Jan;322:503–528. doi: 10.1113/jphysiol.1982.sp014052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Curtis B. M., Catterall W. A. Solubilization of the calcium antagonist receptor from rat brain. J Biol Chem. 1983 Jun 25;258(12):7280–7283. [PubMed] [Google Scholar]
  9. DePover A., Lee S. W., Matlib M. A., Whitmer K., Davis B. A., Powell T., Schwartz A. [3H]nimodipine specific binding to cardiac myocytes and subcellular fractions. Biochem Biophys Res Commun. 1983 May 31;113(1):185–191. doi: 10.1016/0006-291x(83)90449-7. [DOI] [PubMed] [Google Scholar]
  10. Ehlert F. J., Itoga E., Roeske W. R., Yamamura H. I. The interaction of [3H]nitrendipine with receptors for calcium antagonists in the cerebral cortex and heart of rats. Biochem Biophys Res Commun. 1982 Feb 11;104(3):937–943. doi: 10.1016/0006-291x(82)91339-0. [DOI] [PubMed] [Google Scholar]
  11. Ehlert F. J., Roeske W. R., Itoga E., Yamamura H. I. The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats. Life Sci. 1982 Jun 21;30(25):2191–2202. doi: 10.1016/0024-3205(82)90293-4. [DOI] [PubMed] [Google Scholar]
  12. Fenwick E. M., Marty A., Neher E. Sodium and calcium channels in bovine chromaffin cells. J Physiol. 1982 Oct;331:599–635. doi: 10.1113/jphysiol.1982.sp014394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Glossmann H., Ferry D. R. Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine. Naunyn Schmiedebergs Arch Pharmacol. 1983 Aug;323(4):279–291. doi: 10.1007/BF00512465. [DOI] [PubMed] [Google Scholar]
  14. Gould R. J., Murphy K. M., Snyder S. H. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine. Mol Pharmacol. 1984 Mar;25(2):235–241. [PubMed] [Google Scholar]
  15. Hagiwara S., Byerly L. Calcium channel. Annu Rev Neurosci. 1981;4:69–125. doi: 10.1146/annurev.ne.04.030181.000441. [DOI] [PubMed] [Google Scholar]
  16. Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981 Aug;391(2):85–100. doi: 10.1007/BF00656997. [DOI] [PubMed] [Google Scholar]
  17. Hay D. W., Wadsworth R. M. Effects of some organic calcium antagonists and other procedures affecting Ca2+ Translocation on KCl-induced contractions in the rat vas deferens. Br J Pharmacol. 1982 May;76(1):103–113. doi: 10.1111/j.1476-5381.1982.tb09195.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol. 1977 Apr;69(4):497–515. doi: 10.1085/jgp.69.4.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hondeghem L. M., Katzung B. G. Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta. 1977 Nov 14;472(3-4):373–398. doi: 10.1016/0304-4157(77)90003-x. [DOI] [PubMed] [Google Scholar]
  20. Janis R. A., Scriabine A. Sites of action of Ca2+ channel inhibitors. Biochem Pharmacol. 1983 Dec 1;32(23):3499–3507. doi: 10.1016/0006-2952(83)90295-2. [DOI] [PubMed] [Google Scholar]
  21. Janis R. A., Triggle D. J. New developments in Ca2+ channel antagonists. J Med Chem. 1983 Jun;26(6):775–785. doi: 10.1021/jm00360a001. [DOI] [PubMed] [Google Scholar]
  22. Kanmura Y., Itoh T., Suzuki H., Ito Y., Kuriyama H. Effects of nifedipine on smooth muscle cells of the rabbit mesenteric artery. J Pharmacol Exp Ther. 1983 Jul;226(1):238–248. [PubMed] [Google Scholar]
  23. Kass R. S. Nisoldipine: a new, more selective calcium current blocker in cardiac Purkinje fibers. J Pharmacol Exp Ther. 1982 Nov;223(2):446–456. [PubMed] [Google Scholar]
  24. Kostyuk P. G. Intracellular perfusion of nerve cells and its effects on membrane currents. Physiol Rev. 1984 Apr;64(2):435–454. doi: 10.1152/physrev.1984.64.2.435. [DOI] [PubMed] [Google Scholar]
  25. Lee K. S., Tsien R. W. Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature. 1983 Apr 28;302(5911):790–794. doi: 10.1038/302790a0. [DOI] [PubMed] [Google Scholar]
  26. Miller R. J., Freedman S. B. Are dihydropyridine binding sites voltage sensitive calcium channels? Life Sci. 1984 Mar 26;34(13):1205–1221. doi: 10.1016/0024-3205(84)90543-5. [DOI] [PubMed] [Google Scholar]
  27. Murphy K. M., Snyder S. H. Calcium antagonist receptor binding sites labeled with [3H]nitrendipine. Eur J Pharmacol. 1982 Jan 22;77(2-3):201–202. doi: 10.1016/0014-2999(82)90021-8. [DOI] [PubMed] [Google Scholar]
  28. Sarmiento J. G., Janis R. A., Colvin R. A., Triggle D. J., Katz A. M. Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle. J Mol Cell Cardiol. 1983 Feb;15(2):135–137. doi: 10.1016/0022-2828(83)90289-4. [DOI] [PubMed] [Google Scholar]
  29. Schwarz W., Palade P. T., Hille B. Local anesthetics. Effect of pH on use-dependent block of sodium channels in frog muscle. Biophys J. 1977 Dec;20(3):343–368. doi: 10.1016/S0006-3495(77)85554-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tsien R. W. Calcium channels in excitable cell membranes. Annu Rev Physiol. 1983;45:341–358. doi: 10.1146/annurev.ph.45.030183.002013. [DOI] [PubMed] [Google Scholar]
  31. Williams L. T., Jones L. R. Specific binding of the calcium antagonist [3H]nitrendipine to subcellular fractions isolated from canine myocardium. Evidence for high affinity binding to ryanodine-sensitive sarcoplasmic reticulum vesicles. J Biol Chem. 1983 May 10;258(9):5344–5347. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES